WO2022058871 - SOLID FORMS OF A CDK4 INHIBITOR
National phase entry:
Publication Number
WO/2022/058871
Publication Date
24.03.2022
International Application No.
PCT/IB2021/058320
International Filing Date
13.09.2021
Title **
[English]
SOLID FORMS OF A CDK4 INHIBITOR
[French]
FORMES SOLIDES D'UN INHIBITEUR DE CDK4
Applicants **
PFIZER INC.
66 Hudson Boulevard East
New York, NY 10001-2192, US
Inventors
CLARK, Wesley Dewitt
c/o Pfizer Inc.
445 Eastern Point Road, Building 98
Groton, Connecticut 06340, US
DEAL, Judith Gail
c/o Pfizer Inc.
10777 Science Center Drive
San Diego, California 92121, US
SAMAS, Brian Matthew
c/o Pfizer Inc.
445 Eastern Point Road, Building 98
Groton, Connecticut 06340, US
Priority Data
63/078,636
15.09.2020
US
63/240,268
02.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2003 | |
| EPO | Filing, Examination | 9395 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 7760 |
Total: 20355 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
-pentitol, to pharmaceutical compositions comprising such solid forms, and to use of such solid forms and pharmaceutical compositions for the treatment of cancer.[French]
-pentitol, des compositions pharmaceutiques comprenant de telles formes solides, et l'utilisation de telles formes solides et de telles compositions pharmaceutiques pour le traitement du cancer.